ArticlePloS one2012
arrayMap: a reference resource for genomic copy number imbalances in human malignancies.
Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The Progenetix oncogenomic resource in 2021.Database : the journal of biological databases and curation · 2021Pooled it
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma.Cancer cell · 2017Pooled it
- Article
- AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer.International journal of molecular sciences · 2023Article
- Insights into the Peritumoural Brain Zone of Glioblastoma:International journal of molecular sciences · 2023Article
- Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.Journal of molecular histology · 2020Article
- Article
- The ELIXIR Human Copy Number Variations Community: building bioinformatics infrastructure for research.F1000Research · 2020Article
- A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.Cancer science · 2018Article
- ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas.Frontiers in neurology · 2018Article
- GenomeCAT: a versatile tool for the analysis and integrative visualization of DNA copy number variants.BMC bioinformatics · 2017Article
- CNARA: reliability assessment for genomic copy number profiles.BMC genomics · 2016Article
- Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.Oncotarget · 2016Article
- Article
- The SIB Swiss Institute of Bioinformatics' resources: focus on curated databases.Nucleic acids research · 2016Article
- arrayMap 2014: an updated cancer genome resource.Nucleic acids research · 2015Article
- Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes.PloS one · 2015Article
- Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.BMC genomics · 2014Article
- Progenetix: 12 years of oncogenomic data curation.Nucleic acids research · 2014Article
- Genomic profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe delineation of genomic copy number abnormalities (CNAs) from cancer samples has been instrumental for identification of tumor suppressor genes and oncogenes and proven useful for clinical marker detection. An increasing number of projects have mapped CNAs using high-resolution microarray based techniques. So far, no single resource does provide a global collection of readily accessible oncogenomic array data. METHODOLOGY/PRINCIPAL
findingsWe here present arrayMap, a curated reference database and bioinformatics resource targeting copy number profiling data in human cancer. The arrayMap database provides a platform for meta-analysis and systems level data integration of high-resolution oncogenomic CNA data. To date, the resource incorporates more than 40,000 arrays in 224 cancer types extracted from several resources, including the NCBI's Gene Expression Omnibus (GEO), EBI's ArrayExpress (AE), The Cancer Genome Atlas (TCGA), publication supplements and direct submissions. For the majority of the included datasets, probe level and integrated visualization facilitate gene level and genome wide data review. Results from multi-case selections can be connected to downstream data analysis and visualization tools. CONCLUSIONS/SIGNIFICANCE: To our knowledge, currently no data source provides an extensive collection of high resolution oncogenomic CNA data which readily could be used for genomic feature mining, across a representative range of cancer entities. arrayMap represents our effort for providing a long term platform for oncogenomic CNA data independent of specific platform considerations or specific project dependence. The online database can be accessed at http//www.arraymap.org.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.